Pharmacokinetics of obinutuzumab in Chinese patients with B‐cell lymphomas
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13232
Abstract: Aim The Phase Ib GERSHWIN study (NCT01680991) assessed the pharmacokinetic (PK) profile of obinutuzumab following multiple intravenous (i.v.) doses to Chinese patients with B‐cell lymphomas, and compared findings with previous obinutuzumab PK studies in mainly… read more here.
Keywords: cell lymphomas; non chinese; pharmacokinetics obinutuzumab; chinese patients ... See more keywords